1. Wilke, R. J., Burke, L. B., & Erickson, P. (2004). Measuring treatment impact: A review of patient-reported outcomes and other efficacy endpoints in approved labels. Control Clinical Trials, 25, 535–52.
2. Food and Drug Administration. (February 2006). Guidance for industry –patient-reported outcome measures: Use in medical product development to support labeling claims. Silver Spring, MD: FDA.
3. Committee for Medicinal Products for Human Use. (July 2005). Reflection Paper on the regulatory guidance for the use of Health-Related Quality of Life (HRQL) measures in the evaluation of medicinal products. London: EMEA.
4. Food and Drug Administration Modernization Act, 1997. Available at http://www.fda.gov/cder/guidance. Accessed September 9, 2004.
5. Lohr, K. (2002). Assessing health status and quality-of-life instruments: Attributes and review criteria. Quality of Life Research, 11, 193–05.